550
Views
50
CrossRef citations to date
0
Altmetric
Orginal Articles

Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles

, , , , , , & show all
Pages 963-973 | Received 12 Jul 2011, Accepted 26 Apr 2012, Published online: 27 Jul 2012

References

  • Araujo J, Nel A. 2009. Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part Fibre Toxicol 6:24.
  • Borron PJ, Mostaghel EA, Doyle C, Walsh ES, McHeyzer-Williams MG, Wright JR. 2002. Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms. J Immunol 169(10):5844–5850.
  • Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KB. 2002. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J Immunol 169(6):2892–2899.
  • Clement CG, Evans SE, Evans CM, Hawke D, Kobayashi R, Reynolds PR, 2008. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am J Respir Crit Care Med 177:322–1330.
  • COMEAP: Committee on the Medical Effects of Air Pollution. 2010. The mortality effects of long-term exposure to particulate air pollution in the United Kingdom. London; UK: HMSO.
  • Duvoix A, Mackay R-M, Henderson N, McGreal E, Postle A, Reid K, 2011. Physiological concentration of calcium inhibits elastase-induced cleavage of a functional recombinant fragment of surfactant protein D. Immunobiology 216(1-2):72–79.
  • Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, 2003. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115(1):13–23.
  • Gehr P, Blank F, Rothen-Rutishauser BM. 2006. Fate of inhaled particles after interaction with the lung surface. Paediatr Respir Rev 7:S73–S75.
  • Geijtenbeek TBH, Gringhuis SI. 2009. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9:465.
  • Geiser M, Kreyling W. 2010. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7:2.
  • Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. 2003. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 171(6):3128–3135.
  • Håkansson K, Lim NK, Hoppe HJ, Reid KB. 1999. Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure 7(3):255–264.
  • Hansen S, Lo B, Evans K, Neophytou P, Holmskov U, Wright JR. 2007. Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol 36(1):94–102.
  • Hawgood S, Brown C, Edmondson J, Stumbaugh A, Allen L, Goerke J, Clark H, Poulain F. 2004. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol 78(16):8565–8572.
  • Head JF, Mealy TR, McCormack FX, Seaton BA. 2003. Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem 278(44):43254–43260.
  • Hillaireau H, Couvreur P. 2009. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66:2873–2896.
  • Johnson CJ, Zhukovsky N, Cass AE, Nagy JM. 2008. Proteomics, nanotechnology and molecular diagnostics. Proteomics 8:715–730.
  • Kang X, Li N, Wang M, Boontheung P, Sioutas C, Harkema JR, 2010. Adjuvant effects of ambient particulate matter monitored by proteomics of bronchoalveolar lavage fluid. Proteomics 10:520–531.
  • Kendall K, Kendall M, Rehfeld F. 2010b. Adhesion of cells, viruses and nanoparticles. Netherlands: Springer.
  • Kendall M, Ding P, Kendall K. 2010a. Submicron and nanoparticle interactions with fibrinogen: the importance of aggregation state. Nanotoxicology; submitted October 2009, accepted April 2010a.
  • Kendall M, Guntern J, Lockyer NP, Jones FH, Hutton BM, Lippmann M, 2004. Urban PM2.5 surface chemistry and interactions with bronchoalveolar lavage fluid. Inhal Toxicol 16:115–129.
  • Kendall M, Tetley TD, Wigzell E, Hutton B, Nieuwenhuijsen M, Luckham P. 2002. Lung lining liquid modifies PM2.5 in favor of particle aggregation: a protective mechanism. Am J Physiol Lung Cell Mol Physiol 282:L109–L114.
  • Kendall M. 2007. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol 293:L1053–L1058.
  • Kendall M, Ding P, Kendall K. 2011. Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology. Nanotoxicology; 5:(1):55–65.
  • Korfhagen TR, Sheftelyevich V, Burhans MS, Bruno MD, Ross GF, Wert SE, 1998. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 273(43):28438–28443.
  • Lawson PR, Reid KB. 2000. The roles of surfactant proteins A and D in innate immunity. Immunol Rev 173:66–78; Review.
  • Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, 2009. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 34:95–102.
  • Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci 105:14265–14270.
  • Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. 539 NanoToday 3:40–47.
  • Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, 2001; Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by aspergillus fumigatus antigens and allergens. J Clin Invest 107(4):467–753.
  • Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U. 2000. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 164(11):5866–5870.
  • Miller B. 2010. Report on estimation of mortality impacts of particulate air pollution in London, IOM Report to Mayor of London.
  • Ni M, Evans DJ, Hawgood S, Anders EM, Sack RA, Fleiszig SM. 2005. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by pseudomonas aeruginosa. Infect Immun 73(4):2147–2156.
  • Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839.
  • Orgeig S, Hiemstra PS, Veldhuizen EJ, Casals C, Clark HW, Haczku A, 2010. Recent advances in alveolar biology: evolution and function of alveolar proteins. Respir Physiol Neurobiol 173(Suppl):S43–S54.
  • Palaniyar N, Clark H, Nadesalingam J, Hawgood S, Reid KB. 2003. Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo. Ann NY Acad Sci 1010:471–475.
  • Peters A, Döring A, Wichmann HE, Koenig W. 1997. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 349(9065):1582–1587.
  • Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001;103(23):2810–2815.
  • Russell AG, Brunekreef B. 2009. A focus on particulate matter and health. Environ Sci Technol 43:4620.
  • Salvador-Morales C, Townsend P, Flahaut E, Venien-Bryan C, Vlandas A, Green MLH, 2007. Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms. Carbon 45:607–617.
  • Shrive AK, Tharia HA, Strong P, Kishore U, Burns I, Rizkallah PJ, 2003. High-resolution structural insights into ligand binding and immune cell recognition by human lung surfactant protein D. J Mol Biol 331(2):509–523.
  • Spira-Cohen A, Chen LC, Kendall M, Lall R, Thurston GD. 2011. Personal exposures to traffic-related air pollution and acute respiratory health among Bronx school children with asthma. Environ Health Perspect 119(4):559–565.
  • Strong P, Kishore U, Morgan C, Lopez Bernal A, Singh M, Reid KB. 1998. A novel method for purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J Immunol Methods 220:139–149.
  • Strong P, Reid KB, Clark H. 2002. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of aspergillus fumigatus. Clin Exp Immunol 130(1):19–24.
  • Tuvim MJ, Evans SE, Clement CG, Dickey BF, Gilbert BE. 2009. Augmented lung inflammation protects against Influenza A Pneumonia. PLoS One 4(1):e4176.
  • Wang JY, Kishore U, Lim BL, Strong P, Reid KB. 1996. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol 106(2):367–373.
  • Wright JR. 2005. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5:58–68.
  • Zhang L, Wang M, Kang X, Boontheung P, Li N, Nel AE, 2009. Oxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluid. J Proteome Res 8(4):1631–1638.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.